NCT05472792View on ClinicalTrials.gov

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

April 15, 2027

Study Completion Date

April 15, 2032

Conditions
Breast CancerQuality of Life
Interventions
RADIATION

Accelerated Partial Breast Irradiation (APBI)

Radiation treatment delivered to the lumpectomy cavity.

DRUG

tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene

Adjuvant endocrine therapy (tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene) for duration of 5 years, as tolerated by the patient.

Trial Locations (1)

27599

RECRUITING

University of North Carolina, Chapel Hill

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER